Health
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia | NEJM – nejm.org
Original Article from The New England Journal of Medicine — Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Trial Design and Randomization
In this trial, which was conducted at 62 hospitals in nine countries in Europe and North America (Canada, Denmark, France, Germany, Italy, the Netherlands, Spain, the United Kingdom, and the United States), we enrolled adults (18 years of age) with severe Covid-19 pneumonia, as confirmed by positive polymerase-chain-reaction (PCR) assay of any body fluid and evidenced by bilateral chest infiltrates on chest radiography or computed tomography. Eligible patients had…
-
General24 hours agoAuthorities say charged man used false name to escape from Perth court
-
Noosa News23 hours agoSkybound Gymnastics owner and coach Wei Jun Lee charged with sexual assault of teenager
-
Noosa News22 hours agoChild sex offenders to be known in Queensland public registry
-
General22 hours agoThousands flood cities demanding action on Palestine